| Q46299714 | Antiparkinsonian Effects of Aqueous Methanolic Extract of Hyoscyamus niger Seeds Result From its Monoamine Oxidase Inhibitory and Hydroxyl Radical Scavenging Potency |
| Q44627789 | Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice |
| Q34420632 | Behavioral phenotyping of the MPTP mouse model of Parkinson's disease |
| Q44580790 | Chromosomal loci influencing the susceptibility to the parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. |
| Q33488710 | Differential response of C57BL/6J mouse and DBA/2J mouse to optic nerve crush |
| Q37441746 | Genetic factors in neurotoxicology and neuropharmacology: a critical evaluation of the use of genetics as a research tool |
| Q38070400 | MPTP mouse models of Parkinson's disease: an update |
| Q73405622 | Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice |
| Q36156158 | Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta |
| Q42602624 | Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease |
Search more.